In contrast to the apparent adverse roles of SLFN5 and SLFN12L in gastric cancer, analysis of gastric carcinomas from 169 patients suggested that high SLFN11 expression correlates with better survival, which improves when patients are treated with platinum-chemotherapy [65]. The gene discussed is SLFN11; the disease is gastric cancer.